Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist
Top epidemiologist Dr Raman Gangakhedkar said the risk of rare side effects is the highest after the first dose of the AstraZeneca vaccine, but lowers with the second and is lowest with the third